Literature DB >> 25821596

Predictors of Mortality among Adult Antiretroviral Therapy Users in Southeastern Ethiopia: Retrospective Cohort Study.

Tesfaye Setegn1, Abulie Takele2, Tesfaye Gizaw3, Dabere Nigatu2, Demewoz Haile4.   

Abstract

Background. Although efforts have been made to reduce AIDS-related mortality by providing antiretroviral therapy (ART) services, still people are dying while they are on treatment due to several factors. This study aimed to investigate the predictors of mortality among adult antiretroviral therapy (ART) users in Goba Hospital, Southeast Ethiopia. Methods. The medical records of 2036 ART users who enrolled at Goba Hospital between 2007 and 2012 were reviewed and sociodemographic, clinical, and ART-related data were collected. Multivariable Cox proportional hazards regression model was used to measure risk of death and identify the independent predictors of mortality. Results. The overall mortality incidence rate was 20.3 deaths per 1000 person-years. Male, bedridden, overweight/obese, and HIV clients infected with TB and other infectious diseases had higher odds of death compared with their respective counterparts. On the other hand, ART clients with primary and secondary educational level and early and less advanced WHO clinical stage had lower odds of death compared to their counterparts. Conclusion. The overall mortality incidence rate was high and majority of the death had occurred in the first year of ART initiation. Intensifying and strengthening early ART initiation, improving nutritional status, prevention and control of TB, and other opportunistic infections are recommended interventions.

Entities:  

Year:  2015        PMID: 25821596      PMCID: PMC4364127          DOI: 10.1155/2015/148769

Source DB:  PubMed          Journal:  AIDS Res Treat        ISSN: 2090-1240


1. Introduction

Antiretroviral therapy (ART) has drastically improved the survival of patients who suffer from HIV/AIDS [1]. The primary goals of ART are as follows: maximal and durable suppression of viral replication, restoration of immunologic function, reduction of HIV-related morbidity and mortality, improvement of quality of life, and prolonging survival [2, 3]. Global commitment to scale up HIV treatment in resource-limited settings is bearing fruit. The fast growth in ART coverage represents one of the great public health success stories in recent history of HIV care that lead to reduction of mortality and improvement of quality of life of people living with HIV/AIDS (PLWHA) [1, 3]. The government of Ethiopia has been working on the scaling up of ART for all people to reduce AIDS-related morbidity and mortality. Ethiopian Ministry of Health (MOH) introduced ART since 2003 on subsidized, fee-based scheme and has developed national guidelines on the use of ART. Since 2005, ART became freely available. Further, ART service was decentralized to health centers in 2006, which marked the rapid scale-up phase in the history of the Ethiopian ART program. In addition to adopting the World Health organization (WHO) recommended public health approach, Ethiopia used innovative models such as a nationwide campaign to achieve national targets both for ART and HIV testing and counseling [4-6]. The recent government report indicated that there were 274,805 patients (69% ART coverage) who were alive and on ART by mid-2012 [7]. ART in Ethiopia included Stavudine (D4T), Lamivudine (3TC), Nevirapine (NVP), Zidovudine (AZT), 3TC-NVP, D4T- 3TC-Efavirenz (EFV), and AZT-3TC-EFV prescribed to 46%, 18%, 23%, and 13%, respectively [8]. Despite the scale-up of ART, early mortality is a major challenge. High rates of early mortality were reported from a number of Sub-Saharan African ART programs [9-11]. Age, sex, educational status, place of residence, WHO clinical stage, CD4, Hemoglobin, nutrition, functional status, and opportunistic infections have been associated with mortality among clients on ART [12-15]. However, those factors which contribute to the deaths of HIV-infected patients while on ART are not well explored particularly in Southeast Ethiopia. Therefore, this study aimed to investigate the predictors of mortality among adult ART users in Goba Hospital, Southeast Ethiopia.

2. Methods

2.1. Study Setting and Period

The study was conducted in Goba Hospital, which is one of the public Hospitals in Bale Zone, located in Goba town 444 kilometers Southeast of Addis Ababa. The hospital has four major departments and one ART clinic. The ART clinic was established in 2005/6 after the Ethiopian government launched free ART service. Currently the ART clinic is providing basic HIV care and treatment. The data collection was conducted from March to April 2013.

2.2. Study Design and Sampling Procedure

A retrospective cohort study was conducted on adult ART users. Both ART experienced and ART naïve clients who started treatment in the time frame from 2007 to 2012 (5 years retrospective follow-up) were included in the study. Medical records of adults (>15 years old) initiating ART between 2007 and 2012 were examined.

2.3. Data Collection and Quality Control

Data were extracted using the Federal Ministry of Health (FMOH) HIV care/ART follow-up format as a data extraction tool. The data were extracted by a trained hospital ART service data clerk. The data extraction format includes sociodemographic characteristics (age, sex, marital status, educational level, and occupational status), functional status, duration on ART (measured in months), nutritional status (measured by BMI), WHO clinical staging (from stage I to stage IV), and clinical and laboratory markers. Functional status (bedridden, ambulatory, and working) was recorded from the patients' card and measured based on the status of patient at initiation of ART. The data collection/extraction process was supervised by the investigators. All completed data were examined for clarity and consistency on daily basis before analysis.

2.4. Data Analysis

Data were checked for completeness and inconsistencies, coded, entered, cleaned, and analyzed using SPSS for Windows version 20.0 (IBM SPSS Statistics, IBM Corp., New York). Descriptive statistics such as median, interquartile range (IQR), and mean and standard deviation (±SD) were used to summarize the characteristics of the cohort. Person time (years) contribution of each study participant was calculated by comparing ART initiation time and death as an outcome variable. All AIDS-related deaths (which might include deaths due to opportunistic infections secondary to poor adherence to both ART regimen and prophylactic antibiotics) were recorded. ART clients who were lost to follow-up, transferred out, and dropped out were considered as censored. The Kaplan Meier (KM) curve with Log Rank test was used to describe the survival time of ART patients based on initial CD4 count and WHO clinical stage at initiation of ART. Bivariate and multivariable Cox proportional hazards regression models were used to identify predictors of mortality. Those variables found statistically significant in the bivariate analysis (P < 0.05) were entered into multivariable Cox proportional hazards regression model to identify the independent predictors (adjusted for potential confounders) of mortality and estimate the adjusted hazard ratios (AHR). Both crude and adjusted hazard ratios (HRs) with 95% confidence intervals were reported. Variables which were statistically significant at P value <0.05 were concluded as predictors of mortality among ART clients.

2.5. Concepts and Definitions of Variables

Duration of treatment and follow-up was time (in months) after initiation of ART. Clinical stages (I–IV) were defined based on the WHO classification for AIDS clients. Mortality/death was defined as any recorded AIDS-related deaths including deaths due to opportunistic infections secondary to delayed ART initiation and poor adherence to both ART regimen and prophylactic antibiotics. In this study a client was considered as lost to follow-up if he/she had not been seen for ≥1 month but <3 months while dropped out clients were those lost to follow-up for >3 months. A client who is transferred to another health facility for care was considered as transferred out. Therefore, all ART clients who were lost to follow-up, transferred out, and dropped out were considered as censored. On the other hand, the concept of functional status of clients was labeled as follows: working, to refer to clients who are able to perform usual work in or out of the house; ambulatory, to refer to clients able to perform activities of daily living; and bedridden, designated to clients who are not able to perform activities of daily living. Ethical Consideration. Ethical clearance was obtained from the Institutional Research Ethics Review Committee, Research and Community Service Directorate Office of Madawalabu University. Letter of permission was obtained from administrative body of Goba Hospital. All information collected from clients' cards was kept anonymous and confidential.

3. Results

3.1. Characteristics of ART Clients

In this cohort study a total of 2036 ART clients were included. More than half 1132 (55.6%) were females and 904 (44.4%) were males. Four hundred twelve (20.2%) of the ART clients had no formal education. The median (IQR) age at ART initiation was 35 years (IQR = 29–38). One thousand seven hundred six (57.8%) and 1197 (58.8%) of ART clients were married and orthodox Christian, respectively (Table 1).
Table 1

Sociodemographic characteristics of ART clients, Goba Hospital, Southeast Ethiopia, 2013.

Sociodemographic variablesFrequency Percent
Age (years)
 15–241798.8
 25–2939319.3
 30–3441920.6
 35–3957228.1
 40–4422010.8
 ≥45 253 12.4 
Sex of participants 
 Male 90444.4
 Female 113255.6
Educational level
 No education41220.2
 Primary68933.8
 Secondary80139.3
 Tertiary1346.6
Occupational status
 Merchant31115.3
 Day laborer30214.8
 Housewife53526.3
 Jobless25712.6
 Farmer23111.3
 Government employee25912.7
 Other* 1416.9
Marital status
 Never married32516.0
 Married 117657.8
 Separated 1386.8
 Divorced28914.2
 Widowed1085.3
Religion
 Orthodox119758.8
 Muslim67032.9
 Protestant1396.8
 Others® 301.5

*Students, construction workers, drivers, and servants, ®Jehovah, wakefeta.

About 1646 (80.8%) of the clients were at working functional status during ART initiation. One thousand one hundred ninety-six (58.7%) of clients initiated ART at WHO clinical stage III. The median baseline CD4 count was 121 per millimeter cube of blood (IQR = 64–169). The median baseline hemoglobin (HgB) was 13.6 mg/dl (IQR = 11 mg/dl–14.6 mg/dl). Three hundred eighty-three (43.3%) of the clients were anemic at initiation of ART (Table 2).
Table 2

Clinical characteristics of ART clients, Goba Hospital, Southeast Ethiopia, 2013.

Baseline* characteristics NumberPercent
Baseline functional status
 Working164680.8
 Ambulatory27613.6
 Bedridden1145.6
WHO stage at ART initiation
 WHO stage I42220.7
 WHO stage II30414.9
 WHO stage III119658.7
 WHO stage IV1145.6
Baseline CD4 count
 ≤200170585.5
 201–30025212.6
 >300371.9
Median CD4 (mm3) (IQR) 121.0 (169.0–64.0) mm3
Baseline HgB level
 Anemic38343.3
 Nonanemic50156.7
Median HgB (mg/dL) (IQR)13.6 mg/dL (11 mg/dL–14.6 mg/dL)
Patient screened for TB
 Yes194095.3
 No964.7
TB coinfection at initiation of ART
 Positive28514.7
 Negative165585.3
Baseline BMI
 <18.5111.3
 18.5–24.975688.6
 ≥25.08610.1
Median weight (Kg) (IQR)50.0 Kg (57 Kg–45 Kg)

*Baseline indicates measurements at initiation of ART.

In this study, out of the total of ART clients, 27.3% of them have been on ART for more than 60 months. Nearly half 1101 (54.1%) were alive and on follow-up while 341 (16.7%) and 474 (23.3%) were lost/dropped out and transferred out, respectively. There were 120 deaths in 5,912 person-years of retrospective follow-up. The overall mortality incidence rate was 20.3 deaths per 1000 person-years. Of the total 120 deaths, majority of 78 (65.0%) occurred in the first year (<12 months) of ART initiation while twenty-two (18.3%) had died after they have been followed up for 12–24 months. The overall mean (95% CI) survival time was 34.9 (95% CI: 33.8–35.9) months after ART initiation (Figure 1).
Figure 1

Survival among a cohort of ART clients, Goba Hospital, Southeast Ethiopia, 2013.

The equality of survival distribution (based on Log Rank test) between different categories of initial CD4 count showed a statistically significant difference in survival of clients based on different categories of initial CD4 (χ 2 = 13.73, Df = 2; P  value < 0.001) (Figure 2).
Figure 2

Survival function stratified according to initial recorded CD4 count among a cohort of ART clients, Goba Hospital, Southeast Ethiopia, 2013.

Similarly, the survival distribution of ART clients based on initial WHO clinical stage showed a statistically significant difference on Log Rank test (χ 2 = 40.01, Df = 3; P  value < 0.001) (Figure 3).
Figure 3

Survival function stratified according to initial WHO clinical stage among a cohort of ART clients; Goba hospital, Southeast Ethiopia; 2013.

3.2. Predictors of Mortality

In our study, multivariable Cox proportional hazards regression analysis showed that male ART clients, ambulatory clients, TB coinfected clients, individuals with baseline BMI ≥ 25 kg/m2, and clients who had opportunistic infection had higher odds of early death compared with their respective counterparts. On the other hand, higher educational status was associated with lower odds of early mortality compared to clients with no formal education. Similarly clients who had better baseline WHO clinical stages (I–III) had lower odds of early mortality compared to clients with baseline WHO clinical stage IV. Male ART clients were 2.6 times more likely to experience early mortality while on ART treatment compared to females (AHR = 2.67; 95% CI: 1.74–4.10). Similarly, bedridden clients were 4.4 times more likely to die early as compared to clients with working functional status (AHR = 4.4; 95% CI: 1.55–12.36). Those ART clients who are TB coinfected at ART initiation were 4.5 times more likely to experience early mortality (AHR = 4.51; 95% CI: 2.86–7.11). On the contrary, those ART clients with primary and secondary education had 72% (AHR = 0.28; 95% CI: 0.11–0.70) and 66% (AHR = 0.34; 95% CI: 0.154–0.728) lower odds of death as compared to clients with no formal education, respectively. Compared to WHO clinical stage IV, being at lower WHO clinical stages (I–III) was found to be protective of early mortality for clients on ART. ART clients with WHO clinical stages I, II, and III had 84%, 66%, and 76% lower odds of early mortality compared with clients with WHO clinical stage IV. However, age of clients, CD4 counts, and anemia status were not significantly associated with odds of death among ART clients (Table 3).
Table 3

Cox regression model: Selected sociodemographic and clinical factors associated with mortality of ART clients in Goba Hospital, Southeast Ethiopia, 2013.

Variables Death as an outcome
Unadjusted HR (95% CI)Adjusted HR (95% CI)
Sex of participants
 Male 3.60 (2.40–5.30)* 2.67 (1.74–4.10)**
 Female 1.01
Educational level
 No formal education1.01.0
 Primary0.34 (0.13–0.84)* 0.28 (0.11–0.70)**
 Secondary0.65 (0.31–1.39)0.34 (0.15–0.73)**
 Tertiary1.53 (0.77–3.05)0.71 (0.34–1.46)
Functional status
 Working1.0
 Ambulatory1.11 (0.41–3.05)1.62 (0.55–4.75)
 Bedridden4.99 (1.80–13.88)* 4.38 (1.55–12.36)**
Baseline WHO stage
 WHO stage 10.17 (0.09–0.33)* 0.16 (0.08–0.33)**
 WHO stage 20.22 (0.11–0.44)* 0.34 (0.16–0.73)**
 WHO stage 30.30 (0.18–0.49)* 0.24 (0.13–0.43)**
 WHO stage 41.0
Baseline CD4 count
 ≤2002.5 (0.3–17.6)
 201–3000.3 (0.03–3.20)
 >3001.0
TB coinfection
 Positive4.7 (3.2–6.8)* 4.51 (2.86–7.11)**
 Negative1.01
Anemia status
 Anemic 0.25 (0.04–1.52)
 Nonanemic1.0
Baseline BMI (kg/m2)
 <18.51.83 (1.20–2.77)* 1.20 (0.77–1.87)
 18.5–24.991.0
 ≥25.03.19 (1.61–6.36)* 3.71 (1.81–7.59)**
Opportunistic infection
 Yes6.27 (4.12–9.54)* 2.51 (1.46–4.31)**
 No1.0
Age group
 15–30 years1.47 (0.88–2.45)
 31–40 years0.84 (0.49–1.42)
 ≥41 years1.0

HR: hazard ratio; *statistically significant at P < 0.05 at the unadjusted HR model; **statistically significant at P < 0.05 at the adjusted HR model (both 2 tailed).

4. Discussion

In this study, there were 120 deaths among ART clients per 5,912 person-years of observation making the overall mortality rate 20.3 deaths per 1,000 person-years. This finding is similar to the finding from Eastern Ethiopia, which reported an overall mortality incidence rate of 2.03/100 person-years [12], whereas studies conducted in rural public hospitals of Southern Nations, Nationalities, and People Regional (SNNPR) state of Ethiopia [16] and Arbaminch hospital [17] have reported higher mortality incidence rates which were 74.5 deaths per 1,000 and 15.4 deaths per 100 person-years, respectively. Our study showed that majority (65%) of the deaths occurred in the first year of ART initiation which was a similar finding with the study conducted in Arbaminch Hospital, Southern Ethiopia [10]. A study from Uganda showed that mortality rate in the first year of ART initiation was 12 deaths per 100 person-years [18]. Early and higher mortality of ART clients in this study was supported by different studies that revealed high early mortality in ART cohort that has been evidenced specially in resource-limited settings [11, 13, 19–21]. Deaths that occurred within the first early months of therapy might result from treatment failure, severe drug toxicity, and regimen changes [22]. Regarding the factors associated with mortality of ART clients, the Cox regression analysis showed that male ART clients were more likely to die compared to female ART clients. This finding is similar to several studies [11, 14, 16, 18, 21, 23–26]. The possible reason for higher risk of mortality among male ART clients might be due to the observed significant difference in the proportion of baseline CD4 count (CD4 at initiation ART) <200/mm3 (P < 0.001) between males and females (90.5% versus 81.6%). The other possible explanation for higher risk of mortality in males might be due to the males' behavioral factors like substance use [27-31]. In our study, those ART clients with higher educational status (primary and secondary education) had lower odds of death compared to those ART clients with no formal education. Many studies documented that higher educational status was associated with lower risk of mortality among ART users [15, 32, 33]. Likewise, those bedridden clients at initiation of ART were more likely to die compared to working functional status clients. In this regard, studies from Nepal and Ethiopia reported supporting evidences that poor baseline performance scale (being bedridden) was a predictor of mortality during ART care [12, 21, 34]. In the same way, WHO clinical stages (I–III) were associated with lower odds of death as compared to clients with WHO clinical stage IV. This indicated that advanced baseline WHO clinical stage was statistically significant clinical predictor of mortality as comparably documented by different studies [11, 12, 14, 16, 25, 35, 36]. In our study, apart from advanced WHO clinical stage, TB coinfection at ART initiation was significantly associated with higher odds of mortality among ART clients as analogously reported by various studies [14, 18, 25, 35, 37]. ART clients who had BMI ≥ 25 Kg/m2 had higher odds of mortality compared with clients with normal BMI (18.5–24.9 Kg/m2) category. Higher odds of death among obese ART clients might be associated with other chronic diseases related to overweight and obesity such as hypertension, diabetes mellitus, and others. Although different studies documented that anemia is a statistically significant predictor of mortality of ART clients [13–15, 25, 34–36], this study did not find statistically significant association between anemia and mortality of ART clients. This study should be interpreted in light of its strengths and limitations. Relatively larger sample size from long period of retrospective follow-up and the use of both clinical and nonclinical data were the strengths of this study. As a limitation, this study used routinely collected health care data which might have been introduced under estimation of mortality due to many unreported/home deaths. On the other hand, since the data were secondary data, authors could not ascertain that all recorded deaths were AIDS-related deaths (which might include deaths due to opportunistic infections secondary to poor adherence to both ART regimen and prophylactic antibiotics). The analysis was restricted only on the variables recorded on the clients' card. Therefore, interpretation and conclusion of finding should take these limitations into account.

5. Conclusion

The overall mortality incidence rate was 20.3 deaths per 1000 person-years. The presence of TB coinfection, WHO clinical stage, being bedridden, educational status, presence of opportunistic infections, and being overweight and obese were factors associated with mortality among ART clients. Initiation of ART at early WHO clinical stage, improving nutritional status, prevention and control of TB, and other opportunistic infections were the recalled recommendations to decrease AIDS-related morality.
  26 in total

1.  Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi.

Authors:  Katie Taylor-Smith; Hannock Tweya; Anthony Harries; Erik Schoutene; Andreas Jahn
Journal:  Malawi Med J       Date:  2010-06       Impact factor: 0.875

2.  Tobacco use in South Africans during 1998: the first demographic and health survey.

Authors:  Krisela Steyn; Debbie Bradshaw; Rosana Norman; Ria Laubscher; Yussuf Saloojee
Journal:  J Cardiovasc Risk       Date:  2002-06

3.  Mortality and loss to follow-up among HAART initiators in rural South Africa.

Authors:  Peter MacPherson; Mosa Moshabela; Neil Martinson; Paul Pronyk
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-11-13       Impact factor: 2.184

4.  Tobacco smoking in Tanzania, East Africa: population based smoking prevalence using expired alveolar carbon monoxide as a validation tool.

Authors:  K Jagoe; R Edwards; F Mugusi; D Whiting; N Unwin
Journal:  Tob Control       Date:  2002-09       Impact factor: 7.552

5.  Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients.

Authors:  Degu Jerene; Are Naess; Bernt Lindtjørn
Journal:  AIDS Res Ther       Date:  2006-04-07       Impact factor: 2.250

6.  Survival status of hiv positive adults on antiretroviral treatment in Debre Markos Referral Hospital, Northwest Ethiopia: retrospective cohort study.

Authors:  Nurilign Abebe; Kassahun Alemu; Tadese Asfaw; Amanuel Alemu Abajobir
Journal:  Pan Afr Med J       Date:  2014-02-03

7.  Rapid scale-up of antiretroviral treatment in Ethiopia: successes and system-wide effects.

Authors:  Yibeltal Assefa; Degu Jerene; Sileshi Lulseged; Gorik Ooms; Wim Van Damme
Journal:  PLoS Med       Date:  2009-04-28       Impact factor: 11.069

8.  Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania.

Authors:  Asgeir Johannessen; Ezra Naman; Bernard J Ngowi; Leiv Sandvik; Mecky I Matee; Henry E Aglen; Svein G Gundersen; Johan N Bruun
Journal:  BMC Infect Dis       Date:  2008-04-22       Impact factor: 3.090

9.  Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, northern Ethiopia: a retrospective cohort study.

Authors:  Kidane Tadesse; Fisaha Haile; Neway Hiruy
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

10.  Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in Far-western region, 2006-2011.

Authors:  Laxmi Bhatta; Elise Klouman; Keshab Deuba; Rachana Shrestha; Deepak Kumar Karki; Anna Mia Ekstrom; Luai Awad Ahmed
Journal:  BMC Infect Dis       Date:  2013-12-26       Impact factor: 3.090

View more
  18 in total

1.  Survival and Predictors of Mortality Among HIV Positive Adult Patients on Highly Active Antiretroviral Therapy in Public Hospitals of Kambata Tambaro Zone, Southern Ethiopia: A Retrospective Cohort Study.

Authors:  Wondimu Abuto; Admas Abera; Tesfaye Gobena; Tariku Dingeta; Melese Markos
Journal:  HIV AIDS (Auckl)       Date:  2021-03-12

2.  Predictors of mortality in a cohort of tuberculosis/HIV co-infected patients in Southwest Ethiopia.

Authors:  Hailay Gesesew; Birtukan Tsehayneh; Desalegn Massa; Amanuel Gebremedhin; Hafte Kahsay; Lillian Mwanri
Journal:  Infect Dis Poverty       Date:  2016-12-05       Impact factor: 4.520

3.  Prevalence and Risk Factors of Mortality among Adult HIV Patients Initiating ART in Rural Setting of HIV Care and Treatment Services in North Western Tanzania: A Retrospective Cohort Study.

Authors:  Daniel Wilfred Gunda; Igembe Nkandala; Semvua Bukheti Kilonzo; Boniface Bartholomew Kilangi; Bonaventura Cornel Mpondo
Journal:  J Sex Transm Dis       Date:  2017-06-15

4.  Factors Associated with Mortality of TB/HIV Co-infected Patients in Ethiopia.

Authors:  Alula M Teklu; Abiy Nega; Admasu Tenna Mamuye; Yohannes Sitotaw; Desta Kassa; Getnet Mesfin; Bekele Belayihun; Girmay Medhin; Kesetebirhan Yirdaw
Journal:  Ethiop J Health Sci       Date:  2017-02

5.  Risk Factors for Mortality among Adult HIV/AIDS Patients Following Antiretroviral Therapy in Southwestern Ethiopia: An Assessment through Survival Models.

Authors:  Dinberu Seyoum; Jean-Marie Degryse; Yehenew Getachew Kifle; Ayele Taye; Mulualem Tadesse; Belay Birlie; Akalu Banbeta; Angel Rosas-Aguirre; Luc Duchateau; Niko Speybroeck
Journal:  Int J Environ Res Public Health       Date:  2017-03-12       Impact factor: 3.390

6.  Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study.

Authors:  Erdaw Tachbele; Gobena Ameni
Journal:  Epidemiol Health       Date:  2016-11-06

7.  Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.

Authors:  Hailay Abrha Gesesew; Paul Ward; Kifle Woldemichael; Lillian Mwanri
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

8.  Effect of cardio-metabolic risk factors on all-cause mortality among HIV patients on antiretroviral therapy in Malawi: A prospective cohort study.

Authors:  Alemayehu Amberbir; Victor Banda; Victor Singano; Alfred Matengeni; Colin Pfaff; Zahra Ismail; Theresa J Allain; Adrienne K Chan; Sumeet K Sodhi; Joep J van Oosterhout
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

Review 9.  Mortality and Its Predictors among HIV Infected Patients Taking Antiretroviral Treatment in Ethiopia: A Systematic Review.

Authors:  Mohammed Biset Ayalew
Journal:  AIDS Res Treat       Date:  2017-10-30

10.  Predictors of Mortality Among Adult HIV-Infected Patients Taking Antiretroviral Therapy (ART) in Harari Hospitals, Ethiopia.

Authors:  Abdi Birhanu; Tariku Dingeta; Moti Tolera
Journal:  HIV AIDS (Auckl)       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.